BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 28888044)

  • 1. Novel mutations in Thai patients with glanzmann thrombasthenia.
    Ittiwut R; Suchartlikitwong P; Kittikalayawong Y; Ittiwut C; Prasopsanti K; Sosothikul D; Shotelersuk V; Suphapeetiporn K
    Eur J Haematol; 2017 Dec; 99(6):520-524. PubMed ID: 28888044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of patients with Glanzmann thrombasthenia and identification of 17 novel mutations.
    Sandrock-Lang K; Oldenburg J; Wiegering V; Halimeh S; Santoso S; Kurnik K; Fischer L; Tsakiris DA; Sigl-Kraetzig M; Brand B; Bührlen M; Kraetzer K; Deeg N; Hund M; Busse E; Kahle A; Zieger B
    Thromb Haemost; 2015 Apr; 113(4):782-91. PubMed ID: 25373348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two homozygous missense mutations in ITGB3 gene as a cause of Glanzmann Thrombasthenia in four consanguineous Pakistani pedigrees.
    Ali T; Gul S; Amar A; Shakoor M; Farhan S; Mohsin S; Khaliq S
    Int J Lab Hematol; 2020 Oct; 42(5):628-635. PubMed ID: 32558238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel mutations of integrin αIIb and β3 genes in Turkish children with Glanzmann's thrombasthenia.
    Tokgoz H; Torun Ozkan D; Caliskan U; Akar N
    Platelets; 2015; 26(8):779-82. PubMed ID: 25734216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanding the Mutation Spectrum Affecting αIIbβ3 Integrin in Glanzmann Thrombasthenia: Screening of the ITGA2B and ITGB3 Genes in a Large International Cohort.
    Nurden AT; Pillois X; Fiore M; Alessi MC; Bonduel M; Dreyfus M; Goudemand J; Gruel Y; Benabdallah-Guerida S; Latger-Cannard V; Négrier C; Nugent D; Oiron RD; Rand ML; Sié P; Trossaert M; Alberio L; Martins N; Sirvain-Trukniewicz P; Couloux A; Canault M; Fronthroth JP; Fretigny M; Nurden P; Heilig R; Vinciguerra C
    Hum Mutat; 2015 May; 36(5):548-61. PubMed ID: 25728920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homozygous point mutations in platelet glycoprotein ITGA2B gene as cause of Glanzmann thrombasthenia in 2 families.
    Sandrock K; Halimeh S; Wiegering V; Kappert G; Sauer K; Deeg N; Busse E; Zieger B
    Klin Padiatr; 2012 Apr; 224(3):174-8. PubMed ID: 22513797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetic diagnosis of Tunisian Glanzmann thrombasthenia patients reveals a common nonsense mutation in the ITGA2B gene that seems to be specific for the studied population.
    Aloui C; Chakroun T; Granados V; Jemni-Yacoub S; Fagan J; Khelif A; Kahloul N; Hammami S; Chkioua L; Barlier C; Cognasse F; Laradi S; Garraud O
    Blood Coagul Fibrinolysis; 2018 Dec; 29(8):689-696. PubMed ID: 30325339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linkage disequilibrium amongst ITGA2B and ITGB3 gene variants in patients with Glanzmann thrombasthenia confirms that most disease-causing mutations are recent.
    Pillois X; Nurden AT
    Br J Haematol; 2016 Nov; 175(4):686-695. PubMed ID: 27469266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular defects in ITGA2B and ITGB3 genes in patients with Glanzmann thrombasthenia.
    Kannan M; Ahmad F; Yadav BK; Kumar R; Choudhry VP; Saxena R
    J Thromb Haemost; 2009 Nov; 7(11):1878-85. PubMed ID: 19691478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico analysis of structural modifications in and around the integrin αIIb genu caused by ITGA2B variants in human platelets with emphasis on Glanzmann thrombasthenia.
    Pillois X; Peters P; Segers K; Nurden AT
    Mol Genet Genomic Med; 2018 Mar; 6(2):249-260. PubMed ID: 29385657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AlphaIIbbeta3 integrin: new allelic variants in Glanzmann thrombasthenia, effects on ITGA2B and ITGB3 mRNA splicing, expression, and structure-function.
    Jallu V; Dusseaux M; Panzer S; Torchet MF; Hezard N; Goudemand J; de Brevern AG; Kaplan C
    Hum Mutat; 2010 Mar; 31(3):237-46. PubMed ID: 20020534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular genetic diagnosis of Glanzmann syndrome in Iranian population; reporting novel and recurrent mutations.
    Zafarghandi Motlagh F; Fallah MS; Bagherian H; Shirzadeh T; Ghasri S; Dabbagh S; Jamali M; Salehi Z; Abiri M; Zeinali S
    Orphanet J Rare Dis; 2019 Apr; 14(1):87. PubMed ID: 31029159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SINE-VNTR-Alu retrotransposon insertion as a novel mutational event underlying Glanzmann thrombasthenia.
    Zhang J; Tang J; Li G; Li N; Wang J; Yao R; Yu T
    J Thromb Haemost; 2023 Dec; 21(12):3597-3607. PubMed ID: 37604334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of one novel pathogenic
    Lu Z; Nikuze L; Zhong Z; Li F; Zhang F; Liang K; Wei M; Wei H
    Platelets; 2020; 31(3):355-359. PubMed ID: 31088191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel and recurrent mutations of ITGA2B and ITGB3 genes in Korean patients with Glanzmann thrombasthenia.
    Park KJ; Chung HS; Lee KO; Park IA; Kim SH; Kim HJ
    Pediatr Blood Cancer; 2012 Aug; 59(2):335-8. PubMed ID: 22190468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and molecular insights into Glanzmann's thrombasthenia in China.
    Zhou L; Jiang M; Shen H; You T; Ding Z; Cui Q; Ma Z; Yang F; Xie Z; Shi H; Su J; Cao L; Lin J; Yin J; Dai L; Wang H; Wang Z; Yu Z; Ruan C; Xia L
    Clin Genet; 2018 Aug; 94(2):213-220. PubMed ID: 29675921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic Confirmation and Identification of Novel Variants for Glanzmann Thrombasthenia and Other Inherited Platelet Function Disorders: A Study by the Korean Pediatric Hematology Oncology Group (KPHOG).
    Yang EJ; Shim YJ; Kim HS; Lim YT; Im HJ; Koh KN; Kim H; Suh JK; Park ES; Lee NH; Choi YB; Hah JO; Lee JM; Han JW; Lee JH; Lee YH; Jung HL; Ha JS; Ki CS; On Behalf Of The Benign Hematology Committee Of The Korean Pediatric Hematology Oncology Group Kphog
    Genes (Basel); 2021 May; 12(5):. PubMed ID: 34066320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the genetic basis of Glanzmann thrombasthenia: implications for treatment.
    Nurden AT; Pillois X; Nurden P
    Expert Rev Hematol; 2012 Oct; 5(5):487-503. PubMed ID: 23146053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. αIIbβ3 variants in ten families with autosomal dominant macrothrombocytopenia: Expanding the mutational and clinical spectrum.
    Morais S; Oliveira J; Lau C; Pereira M; Gonçalves M; Monteiro C; Gonçalves AR; Matos R; Sampaio M; Cruz E; Freitas I; Santos R; Lima M
    PLoS One; 2020; 15(12):e0235136. PubMed ID: 33276370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glanzmann thrombasthenia: a review of ITGA2B and ITGB3 defects with emphasis on variants, phenotypic variability, and mouse models.
    Nurden AT; Fiore M; Nurden P; Pillois X
    Blood; 2011 Dec; 118(23):5996-6005. PubMed ID: 21917754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.